Can an IFU be signed electronically?

Yes. Electronic signatures meet U.S. legal standards under the ESIGN Act (15 U.S.C. ch. 96) and UETA where adopted, provided intent, consent, attribution, and retention are satisfied.

Do IFUs require a notary?

Generally no. Notarization is rarely required for IFUs themselves, but state or institutional policies may demand notarization for associated legal documents.

What level of authentication is needed?

Choose authentication based on risk: email or SMS for low-risk approvals, stronger methods (KBA, MFA) for high-risk signers or regulated attestations.

How should versions be controlled?

Use a versioning system that records author, approver, timestamp, and change summary; retain previous versions per retention policy.

What retention period applies?

Follow HIPAA (6 years) for PHI-related records and internal QMS rules; many organizations retain IFUs for device lifetime plus years for audits.

Who must sign the IFU?

Signatories typically include the product owner, QA lead, and regulatory or clinical approver; the specific authority depends on internal SOPs.

Electronic Signature
Templates
Healthcare
Healthcare IFU Document

Healthcare IFU Document

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

INSTRUCTIONS FOR USE (IFU) — HEALTHCARE DEVICE / PROCEDURE

This Instructions for Use (IFU) accompanies the device or clinical procedure described below and documents that the patient or authorized representative has received, reviewed, and understands the IFU and associated safety information. Patient Name: Patient Identifier:

Patient Information

Full Legal Name

Date of Birth

Gender

Address

Primary Phone

Emergency Contact

Emergency Phone

Insurance Information

Insurance Provider

Policy Number

Group Number

Subscriber Name

Medical History

Current Medications Allergies (include drug, food, material) Prior Surgeries / Procedures Chronic Conditions

Bleeding Disorders / Coagulation Abnormalities Yes No

Device / Procedure Identification

Device or Procedure Name

Model / Catalog

Lot / Batch Number

Serial Number

Manufacturer / Provider Intended Use Indications for Use Contraindications

Reuse / Single-Use Single-use only Reusable (follow cleaning/sterilization instructions)

Instructions for Use — Key Actions

Preparation Step-by-Step Procedure / Use Instructions Maintenance, Cleaning, and Sterilization Storage Conditions Disposal Troubleshooting and Error Conditions Emergency Response

Warnings, Precautions, and Risks

The following warnings and precautions are material to safe use. The patient or authorized representative must acknowledge having read and understood each applicable warning.

Do not use if packaging is damaged, open, or compromised.
May cause allergic reaction; inform provider of known sensitivities.
Use only by trained personnel where indicated; unsupervised use may increase risk.
Do not reuse single-use devices; reuse may result in contamination or malfunction.

Additional Warnings / Precautions

Risks, Benefits, and Alternatives

The patient has been informed of the expected benefits, material risks, and reasonable alternatives to the proposed use of this device or procedure. Material risks can include infection, bleeding, device malfunction, and need for additional treatment. Alternatives may include conservative management, alternative devices, or other procedures as discussed with the provider.

I acknowledge that the provider has explained the risks, benefits, and alternatives and I have had the opportunity to ask questions.

Privacy and Reporting

I acknowledge the provider's privacy practices and understand that personal health information related to this IFU and procedure will be used and disclosed for treatment, billing, and healthcare operations as permitted by law. I understand how to request restrictions and to obtain copies of records from the provider's records custodian.

I acknowledge receipt of the privacy notice and patient information practices as applicable.

Authorization and Expiration

This IFU acknowledgment authorizes the use of the named device or procedure as described herein. Authorization expires on:

Adverse Events and Device Reporting

Any adverse event, device malfunction, or unanticipated problem related to this device or procedure must be reported promptly to the treating provider or institution. The treating provider is responsible for submitting required reports to regulatory authorities as applicable.

Notes to Provider / Additional Instructions

Patient Certification

By signing below I certify that I have read and understand the Instructions for Use provided above, that all material risks and alternatives were explained to me, and that I have had the opportunity to ask questions and to decline or withdraw consent at any time. I understand instructions for use, cleaning, storage and emergency response and agree to follow those instructions unless otherwise instructed by a licensed clinician.

I certify that I understand and accept the information provided in this IFU.

Patient Printed Name:

Relationship (if signing for patient):

Signature:

Date:

What the Healthcare IFU Document Is

A Healthcare IFU Document (Instructions for Use) is a written set of directions and safety information provided with a medical device, diagnostic kit, or clinical product to ensure correct operation, intended use, contraindications, warnings, and maintenance. It explains clinical indications, step-by-step operating procedures, cleaning and storage, symbols and labeling, and adverse event reporting instructions. In regulated contexts the IFU supports regulatory submissions, post-market surveillance, and clinician or patient training by documenting safe, repeatable use and helping organizations meet FDA and other applicable regulatory requirements.

Why a Clear IFU Matters for Patient Safety and Compliance

A well-prepared IFU reduces misuse, clarifies clinical indications and limitations, and supports regulatory compliance. It also documents risk mitigation steps and standardizes training across sites.

Primary Users and Stakeholders

The Healthcare IFU Document is created, reviewed, or relied upon by multiple roles across product and care teams.

Regulatory Affairs and Quality: Draft, review, and align IFU content with FDA labeling guidance and internal quality systems.
Clinical Staff and Caregivers: Use the IFU for safe device operation, indications, and troubleshooting at point of care.
Manufacturers and Technical Writers: Produce, update, and version the IFU to reflect device changes and post-market feedback.

These stakeholders ensure the IFU is accurate, accessible, and retained as part of device records and quality documentation.

Step-by-Step: Prepare and Finalize the IFU

Follow these steps to create, validate, and distribute a compliant IFU for clinical use.

01

Draft Content: Compile intended use, warnings, and stepwise procedures.
02

Clinical Review: Have clinicians verify accuracy and clarity of instructions.
03

Regulatory Check: Confirm labeling meets FDA guidance and applicable standards.
04

Release and Archive: Finalize version, publish to distribution channels, and archive record.

Configure an eWorkflows for IFU Review and Approval

Set up an electronic workflow to route drafts, collect approvals, and capture signatures for each IFU revision.

Field	Configuration
Draft Owner	Assign product or RA lead email for responsibility
Clinical Reviewer	Route to one or more clinician reviewers for verification
Quality Approver	Require QA sign-off before final release
Signature Method	Specify eSignature type and authentication level

Typical Digital IFU Review and Distribution Flow

A concise sequence to move an IFU from draft to distributed, audited record.

Upload Draft: Add document to the e-sign platform or content management system.
Assign Reviewers: Select clinical, regulatory, and quality approvers in order.
Collect Signatures: Use appropriate eSignature authentication and capture audit trail.
Publish & Store: Distribute final IFU and archive with version history.

Technical and Integration Considerations

Choose a platform that supports secure signing, audit trails, and integration with document management systems.

Integrations: Salesforce, NetSuite, Microsoft 365, Google Workspace connectivity
Formats Supported: PDF, DOCX, HTML, Excel input/output
Authentication: Email, SMS code, or advanced signer verification

Ensure the platform can export tamper-evident signed PDFs and store records to meet audit and retention requirements.

Security and Compliance Checklist

Data in Transit: TLS 1.2/1.3

Data at Rest: AES-256 encryption

HIPAA Support: BAA available

Audit Trails: Timestamped action logs

Regulatory: 21 CFR Part 11 support

Certifications: SOC 2 Type II, ISO 27001

eSignature Pricing and Feature Snapshot for IFU Workflows

Compare common vendor price points and core features relevant to healthcare IFU distribution and retention; signNow appears first per vendor listing conventions.

	signNow	DocuSign	Adobe Sign	PandaDoc	HelloSign
Starting Price	$8/user/mo	$15/user/mo	$14/user/mo	$19/user/mo	$15/user/mo
Free Trial	7-day free trial	Yes (varies)	Yes (varies)	Yes (varies)	Yes (varies)
Bulk Send	Yes	Yes	Yes	Yes	No
Audit Trail	Yes	Yes	Yes	Yes	Yes
HIPAA Compliant	Yes	Yes	Yes	No	No

Common Pitfalls When Preparing an IFU

Using ambiguous clinical language that leaves room for varied interpretation can lead to incorrect use and patient harm.
Failing to align the IFU with the device labeling and user interface creates discrepancies during device operation and audits.
Neglecting version control and distribution lists increases the risk that clinicians will use an outdated instruction set.
Overlooking localization needs and measurement units (metric vs imperial) can create operational errors in multi-site deployments.

Consequences of Incomplete or Incorrect IFUs

Regulatory Action: FDA inspection or warning letter

Product Recall: Removal or correction of marketed devices

Civil Liability: Malpractice or product liability claims

HIPAA Fines: Financial penalties for PHI breaches

Operational Disruption: Site-level workflow failures

Reputational Harm: Loss of provider or patient trust

Real-World Examples of Digital IFU Workflows

Practical implementations illustrate how electronic IFUs and signatures reduce turnaround and improve traceability.

Optica Ventures LLC

Their operations team standardized IFU distribution and storage across remote clinics.

Implemented digital routing for clinician approvals.
As a result, turnaround time for final IFU sign-off fell substantially and document auditability improved, enabling faster training and consistent device use across sites.

Fertility Centers of Illinois

Clinical staff needed consistent device instructions across locations.

Adopted electronic IFUs with version control.
That change reduced usage errors, centralized updates, and ensured compliant retention of signed IFU acknowledgments for clinical records and quality audits.

Typical Timelines and Processing Expectations

Timelines vary by organization size and review complexity; plan for parallel clinical and regulatory review to shorten cycles.

Initial Draft Review:

Allow 3–7 business days for clinical and technical review

Regulatory Review:

Expect 5–10 business days depending on changes required

Quality Approval:

QA sign-off commonly takes 2–5 business days

Final Distribution:

Publish to users within 24–48 hours after approvals

Post-Market Update:

Issue corrections promptly; complete distribution within 30 days

FAQs and Troubleshooting for Healthcare IFU Documents

Answers to frequent questions about drafting, signing, and storing Healthcare IFU Documents.

Need help? Contact support

Can an IFU be signed electronically?
Yes. Electronic signatures meet U.S. legal standards under the ESIGN Act (15 U.S.C. ch. 96) and UETA where adopted, provided intent, consent, attribution, and retention are satisfied.
Do IFUs require a notary?
Generally no. Notarization is rarely required for IFUs themselves, but state or institutional policies may demand notarization for associated legal documents.
What level of authentication is needed?
Choose authentication based on risk: email or SMS for low-risk approvals, stronger methods (KBA, MFA) for high-risk signers or regulated attestations.
How should versions be controlled?
Use a versioning system that records author, approver, timestamp, and change summary; retain previous versions per retention policy.
What retention period applies?
Follow HIPAA (6 years) for PHI-related records and internal QMS rules; many organizations retain IFUs for device lifetime plus years for audits.
Who must sign the IFU?
Signatories typically include the product owner, QA lead, and regulatory or clinical approver; the specific authority depends on internal SOPs.

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now